European Union · Question · QUESTION_WRITTEN
E-10-2025-001139
Relocation of pharmaceutical production in Europe and conditions of access to the European market
Introduced
18 March 2025
Last action
7 July 2025 · Answer
Status
answered
Sponsors
Jordan BARDELLA
Subjects
Discovery layer
Source updated
7 July 2025
Records
Official question E-10-2025-001139 from European Union at European Parliament. Dated 18 March 2025. Status: answered.
Timeline
18 March 2025
Written question
Relocation of pharmaceutical production in Europe and conditions of access to the European market
Source: QUESTION_WRITTEN
7 July 2025
Answer
Source: QUESTION_WRITTEN_ANSWER
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
5 official files
Reshoring pharmaceutical production back to Europe and conditions for accessing the European market
Reshoring pharmaceutical production back to Europe and conditions for accessing the European market
QUESTION_WRITTEN · EN · 28 March 2025
Reshoring pharmaceutical production back to Europe and conditions for accessing the European market
QUESTION_WRITTEN · EN · 28 March 2025
Answer
QUESTION_WRITTEN_ANSWER · 7 July 2025
Relocalisation de la production pharmaceutique en Europe et conditions d’accès au marché européen
QUESTION_WRITTEN · FR · 28 March 2025
Relocalisation de la production pharmaceutique en Europe et conditions d’accès au marché européen
QUESTION_WRITTEN · FR · 28 March 2025
Sponsors
- Jordan BARDELLA · AUTHOR
- · COM · ADDRESSEE
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.europarl.europa.eu/doceo/document/E-10-2025-001139_EN.html
- Open data entity: https://data.europarl.europa.eu/api/v2/parliamentary-questions/E-10-2025-001139
- eu · E-10-2025-001139 · source updated 7 July 2025